Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of High-Dose Continuous Intravenous Magnesium Sulfate Infusion Compared With Standard Intravenous Magnesium Sulfate Therapy in Patients With Status Asthmaticus in the Emergency Department

NCT07795970 is registered in ClinicalTrials.gov with Thammasat University as lead sponsor.

NCT NCT07795970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of High-Dose Continuous Intravenous Magnesium Sulfate Infusion Compared With Standard Intravenous Magnesium Sulfate Therapy in Patients With Status Asthmaticus in the Emergency Department
Lead sponsor
Thammasat University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
April 30, 2028
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma exacerbation, emergency department, high dose, magnesuim sulfate